HCA Healthcare stock sits at EUR 402.10, market cap USD 97.5 billion

Published on 10/09/2026 at 20:07 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

HCA Healthcare stock gained 1.31 percent versus EUR 396.90 on October 9, 2026. Results are due October 27, 2026 at 10:00 a.m. Eastern.

Key points in brief

HCA Healthcare stock stood at EUR 402.10 at Lang & Schwarz on October 9, 2026 at 8:05 p.m. CEST, up 1.31 percent versus EUR 396.90.
Market capitalization was USD 97.5 billion and the P/E ratio was 15.07 as of October 9, 2026.
The USD 450.44 NYSE quote sat 19.07 percent below the USD 556.52 52-week high.
RBC Capital lifted its target from USD 435.00 to USD 496.00 on October 7, 2026.

Isometrische 3D-Illustration der Krankenhaus-Wertschöpfungskette: Aufnahme, Diagnose, OP, Pflege, Apotheke — HCA Healthcare US40412C1018 isometrisches Diagramm der Wertschöpfungskette vom Patienten über Diagnose bis zur Apotheke, Illustration mit AI erstellt.

HCA Healthcare stock stood at EUR 402.10 at Lang & Schwarz on October 9, 2026 at 8:05 p.m. CEST, up 1.31 percent versus the EUR 396.90 prior close. Its market capitalization was USD 97.5 billion, giving the after-hours quote a clear valuation context for German investors.

Price stays below yearly high

The primary-market quote was USD 450.44 on the NYSE at 2:06 p.m. ET on October 9, 2026, up 1.22 percent on the session. That level was 19.07 percent below the 52-week high of USD 556.52 and 27.25 percent above the 52-week low of USD 353.99.

Trading volume stood at 348,884 shares against an average of 1,467,609 shares as of October 9, 2026. The gap to average turnover indicates a measured session rather than a volume-led repricing.

Valuation and analyst target

HCA Healthcare carried a P/E ratio of 15.07 as of October 9, 2026. That multiple belongs beside the USD 450.44 NYSE quote, while the EUR 402.10 Lang & Schwarz price remains the reference value for this report.

According to Markets Insider on October 7, 2026, RBC Capital raised its target from USD 435.00 to USD 496.00 and retained an Outperform rating. The new target was 10.11 percent above the USD 450.44 NYSE quote on October 9, 2026.

Comparison with peers

The following peer figures are as of October 9, 2026.

HCA Healthcare (NYSE, USD): plus 1.31 percent, P/E 15.07, market capitalization USD 97.5 billion

Tenet Healthcare (NYSE, USD): plus 1.87 percent, P/E 10.23, market capitalization USD 21.4 billion

Universal Health Services (NYSE, USD): plus 1.29 percent, P/E 7.30, market capitalization USD 10.8 billion

Next results date is October 27

HCA Healthcare scheduled its third-quarter 2026 earnings call for October 27, 2026, at 10:00 a.m. Eastern. The date gives the current market comparison a defined near-term reporting point, while the stock remains below its yearly high.

After-hours price and market context

At Lang & Schwarz, HCA Healthcare stock was trading at EUR 402.10 on October 9, 2026 at 8:05 p.m. CEST, plus 1.31 percent versus the EUR 396.90 prior close. The company is listed on the NYSE under ticker HCA, operates in healthcare and medical care facilities, and is a component of the S&P 500.

The further course of trading is shown by the continuously updated real-time quote of HCA Healthcare stock.